TheBodyPro: Expert analysis from Benjamin Young, M.D., Ph.D.
At first blush, it might feel like there’s little of note in some recently published research exploring the intersection of HIV, pregnancy, hypertension, and antiretroviral therapy (specifically the integrase inhibitor dolutegravir). But when we dig past the surface, we uncover a trove of important findings — and a critical reminder to pay attention to the long-term health indicators of pregnant women, not just the future children they bear.
Read the full analysis here.
Source : TheBodyPro
Related HIV and Co-Infections News
-
The Lancet Global Health: Untangling the complex relationship between HIV-exposure and TB in children: A narrative review
-
WHO certifies the Bahamas for eliminating mother-to-child transmission of HIV
-
ACTG launches landmark study evaluating treatments for depressive disorders with or without mild neurocognitive disorder among people living with HIV
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.